Bussiness5 months ago
IBD 50 Stock Nosedives On A ‘Shocking’ And ‘Alarming’ Report
Medpace (MEDP) stock crumbled late Monday on a “shocking bookings miss” and after the clinical research organization slashed its 2024 sales guidance by $25 million at...
